文献速递脑血管病

心房颤动与抗血栓治疗对脑出血结局的交互作用

Interaction of atrial fibrillation and antithrombotics on outcome in intracerebral hemorrhage.
PubMed 文献 · Neurology · 2019-10-09

这项前瞻性观察研究纳入2所大学医院的1,106例连续脑出血患者,分析心房颤动(AF)与抗血栓预处理对结局的影响。结果显示AF患者占21.9%,其死亡率更高,但校正抗血栓预处理后AF对3个月死亡率无独立影响(OR 1.45,95%CI 0.74-2.85,p=0.284)。AF改变了抗血栓预处理对院内和3个月死亡率的作用(交互p=0.077和0.008)。

要点

  • AF脑出血患者年龄更大、血管风险因素更多、临床更重且死亡率更高。
  • 校正抗血栓预处理后,AF对3个月死亡率无独立影响。
  • 无AF患者中抗血栓预处理增加死亡率,而AF患者中未观察到该效应。

核心结论

  • AF脑出血患者死亡率增加,但校正抗血栓预处理后AF对死亡率无独立影响。
  • 抗血栓预处理对无AF的脑出血患者结局有害,对AF脑出血患者未检测到效应。

研究设计与样本

  • 前瞻性观察研究,纳入2所大学医院的1,106例连续脑出血患者。
  • 按AF存在与否分层描述临床特征,分析院内和3个月死亡率及3个月残疾。

主要发现

  • AF存在于21.9%的原发性脑出血病例中。
  • AF脑出血患者年龄更大、血管风险因素更多、抗血栓预处理更多、临床严重度更高、血肿体积更大、院内和3个月死亡率更高。
  • AF脑出血病例更常应用不复苏医嘱。
  • 经过2种不同校正模型后,AF脑出血患者死亡率仍显著更高。
  • 引入既往抗血栓治疗后,AF脑出血相比非AF病例的3个月死亡率校正OR为1.45(95%CI 0.74-2.85,p=0.284)。

临床怎么用

  • 评估脑出血患者预后时应考虑AF状态与抗血栓预处理的交互作用。
  • 对无AF的脑出血患者,抗血栓预处理与死亡率增加相关,需谨慎权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the clinical differences between patients with primary intracerebral hemorrhage (ICH) with and without atrial fibrillation (AF) and assess whether the effect of the antithrombotic pretreatment on outcome is modified by the presence of AF. METHODS: In this prospective observational study, researchers from 2 university hospitals included 1,106 consecutive patients with ICH. Clinical characteristics were described and stratified by presence of AF. In-hospital and 3-month mortality and 3-month disability were analyzed, considering antithrombotic pretreatment (none, antiplatelets, or oral anticoagulants) and AF (yes/no). RESULTS: AF was present in 21.9% of primary ICH cases. Patients with AF-ICH were older, with more vascular risk factors, more antithrombotic pretreatment, higher clinical severity, higher hematoma volume, and higher in-hospital and 3-month mortality. Do-not-resuscitate orders were applied more frequently in AF-ICH cases. After 2 different adjustment models, mortality remained significantly higher in patients with AF-ICH. However, after introducing previous antithrombotic treatment in the model, the adjusted odds ratio for 3-month mortality was 1.45 (95% confidence interval 0.74-2.85, p = 0.284) for patients with AF-ICH compared with non-AF cases. AF modified the effect of antithrombotic pretreatment on in-hospital (p int = 0.077) and 3-month mortality (p int = 0.008). Among patients without AF, antithrombotic pretreatment increased mortality; no effect was observed in patients with AF-ICH. CONCLUSIONS: Patients with AF and ICH had increased mortality; however, AF had no independent effect on mortality after adjustment for antithrombotic pretreatment. Conversely, antithrombotic pretreatment had a deleterious effect on outcome in patients with ICH without AF, but no detectable effect in patients with AF with ICH.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Roquer J, Vivanco-Hidalgo RM, Prats-Sánchez LL, et al. Interaction of atrial fibrillation and antithrombotics on outcome in intracerebral hemorrhage. Neurology. 2019. PMID: 31597709. doi:10.1212/WNL.0000000000008462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。